Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
P. Stute, L. Wildt & J. Neulen. (2018) The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric 21:2, pages 111-122.
Read now
Read now
C. J. Haines & E. Farrell. (2010) Menopause management: a cardiovascular risk-based approach. Climacteric 13:4, pages 328-339.
Read now
Read now
Angiolo Gadducci, Nicoletta Biglia, Stefania Cosio, Piero Sismondi & Andrea Riccardo Genazzani. (2010) Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy. Gynecological Endocrinology 26:8, pages 568-577.
Read now
Read now
Angiolo Gadducci, Nicoletta Biglia, Stefania Cosio, Piero Sismondi & Andrea Riccardo Genazzani. (2009) Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: A debated clinical issue. Gynecological Endocrinology 25:12, pages 807-815.
Read now
Read now
Marc Espié, Pierre Mares, Pia de Reilhac, Thierry Chevallier & Jean-Pierre Daurès. (2006) Breast cancer in postmenopausal women with and without hormone replacement therapy: Preliminary results of the MISSION study. Gynecological Endocrinology 22:8, pages 423-431.
Read now
Read now
M. Gambacciani & A. R. Genazzani. (2003) The study with a million women (and hopefully fewer mistakes). Gynecological Endocrinology 17:5, pages 359-362.
Read now
Read now
Alastair MacLennan & David Sturdee. (2002) The end of WISDOM. Climacteric 5:4, pages 313-316.
Read now
Read now
Articles from other publishers (51)
Patricia Geraghty. 2022. Each Woman’s Menopause: An Evidence Based Resource. Each Woman’s Menopause: An Evidence Based Resource
121
143
.
Winnifred Cutler, James Kolter, Catherine Chambliss, Heather O’Neill & Hugo M. Montesinos-Yufa. (2020) Long term absence of invasive breast cancer diagnosis in 2,402,672 pre and postmenopausal women: A systematic review and meta-analysis. PLOS ONE 15:9, pages e0237925.
Crossref
Crossref
Xiangyan Ruan & Alfred O. Mueck. (2019) The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue. Hormone Molecular Biology and Clinical Investigation 37:1.
Crossref
Crossref
Kang Wang, Feng Li, Li Chen, Yan-Mei Lai, Xiang Zhang & Hong-Yuan Li. (2017) Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: a systematic review and dose-response meta-analysis of prospective studies. Oncotarget 8:46, pages 81109-81124.
Crossref
Crossref
Jason S. Carroll, Theresa E. Hickey, Gerard A. Tarulli, Michael Williams & Wayne D. Tilley. (2016) Deciphering the divergent roles of progestogens in breast cancer. Nature Reviews Cancer 17:1, pages 54-64.
Crossref
Crossref
Elgene Lim, Gerard Tarulli, Neil Portman, Theresa E Hickey, Wayne D Tilley & Carlo Palmieri. (2016) Pushing estrogen receptor around in breast cancer. Endocrine-Related Cancer 23:12, pages T227-T241.
Crossref
Crossref
Winnifred Cutler, Regula Bürki, James Kolter, Catherine Chambliss, Erika Friedmann & Kari Hart. (2015) Invasive Breast Cancer Incidence in 2,305,427 Screened Asymptomatic Women: Estimated Long Term Outcomes during Menopause Using a Systematic Review. PLOS ONE 10:6, pages e0128895.
Crossref
Crossref
A.O. Mueck & H. Seeger. (2014) Risiko von Brustkrebs unter „hormone replacement therapy“Risk of breast cancer with hormone replacement therapy. Gynäkologische Endokrinologie 12:3, pages 149-155.
Crossref
Crossref
Petra Stute. (2014) Is breast cancer risk the same for all progestogens?. Archives of Gynecology and Obstetrics 290:2, pages 207-209.
Crossref
Crossref
Thunyarat Anothaisintawee, Cholatip Wiratkapun, Panuwat Lerdsitthichai, Vijj Kasamesup, Sansanee Wongwaisayawan, Jiraporn Srinakarin, Siriporn Hirunpat, Piyanoot Woodtichartpreecha, Sarawan Boonlikit, Yot Teerawattananon & Ammarin Thakkinstian. (2013) Risk Factors of Breast Cancer. Asia Pacific Journal of Public Health 25:5, pages 368-387.
Crossref
Crossref
Erika Schwartz & Kent Holtorf. (2011) Hormone Replacement Therapy in the Geriatric Patient: Current State of the Evidence and Questions for the Future. Estrogen, Progesterone, Testosterone, and Thyroid Hormone Augmentation in Geriatric Clinical Practice: Part 1. Clinics in Geriatric Medicine 27:4, pages 541-559.
Crossref
Crossref
Woraluk Somboonporn, Sunida Panna, Teerayut Temtanakitpaisan, Srinaree Kaewrudee & Sukree Soontrapa. (2011) Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women. Menopause 18:10, pages 1060-1066.
Crossref
Crossref
Fahim Atif, Iqbal Sayeed, Seema Yousuf, Tauheed Ishrat, Fang Hua, Jun Wang, Daniel J. Brat & Donald G. Stein. (2011) Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence. Molecular Medicine 17:9-10, pages 1084-1094.
Crossref
Crossref
A.O. Mueck & H. Seeger. (2011) Medikamentöse Therapiemöglichkeiten in der MenopauseMedicinal therapy options in the menopause. Gynäkologische Endokrinologie 9:3, pages 151-157.
Crossref
Crossref
. (2011) Hormone Replacement Therapy and Breast Cancer in Postmenopausal Women. The Journal of Korean Society of Menopause 17:3, pages 125.
Crossref
Crossref
Alfred O. Mueck & Xiangyan Ruan. (2011) Benefits and risks during HRT: main safety issue breast cancer. Hormone Molecular Biology and Clinical Investigation 5:2.
Crossref
Crossref
Nagarajan Vishali, Krishnaswamy Kamakshi, Sekar Suresh & Seppan Prakash. (2011) Red clover Trifolium pratense (Linn.) isoflavones extract on the pain threshold of normal and ovariectomized rats - a long-term study. Phytotherapy Research 25:1, pages 53-58.
Crossref
Crossref
Avrum Z. Bluming & Carol Tavris. (2009) Hormone Replacement Therapy: Real Concerns and False Alarms. The Cancer Journal 15:2, pages 93-104.
Crossref
Crossref
Xiao-Dong Fu, Maria Silvia Giretti, Lorenzo Goglia, Marina Ines Flamini, Angel Matias Sanchez, Chiara Baldacci, Silvia Garibaldi, Regine Sitruk-Ware, Andrea Riccardo Genazzani & Tommaso Simoncini. (2008) Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion. BMC Cancer 8:1.
Crossref
Crossref
Erika T. Schwartz & Kent Holtorf. (2008) Hormones in Wellness and Disease Prevention: Common Practices, Current State of the Evidence, and Questions for the Future. Primary Care: Clinics in Office Practice 35:4, pages 669-705.
Crossref
Crossref
B. Gellersen, M.S. Fernandes & J.J. Brosens. (2008) Non-genomic progesterone actions in female reproduction. Human Reproduction Update 15:1, pages 119-138.
Crossref
Crossref
Marc L’Hermite, Tommaso Simoncini, Sarah Fuller & Andrea Riccardo Genazzani. (2008) Could transdermal estradiol+progesterone be a safer postmenopausal HRT? A review. Maturitas 60:3-4, pages 185-201.
Crossref
Crossref
Harald Seeger & Alfred O. Mueck. (2008) Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause?. The Journal of Steroid Biochemistry and Molecular Biology 109:1-2, pages 11-15.
Crossref
Crossref
Michael Schumacher, Rachida Guennoun, Donald G. Stein & Alejandro F. De Nicola. (2007) Progesterone: Therapeutic opportunities for neuroprotection and myelin repair. Pharmacology & Therapeutics 116:1, pages 77-106.
Crossref
Crossref
Stephen N. Birrell, Lisa M. Butler, Jonathan M. Harris, Grant Buchanan & Wayne D. Tilley. (2007) Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer. The FASEB Journal 21:10, pages 2285-2293.
Crossref
Crossref
Michael Schumacher, Rachida Guennoun, Abdel Ghoumari, Charbel Massaad, Françoise Robert, Martine El-Etr, Yvette Akwa, Krzysztof Rajkowski & Etienne-Emile Baulieu. (2007) Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System. Endocrine Reviews 28:4, pages 387-439.
Crossref
Crossref
Bing Xu, Jo Kitawaki, Hisato Koshiba, Hiroaki Ishihara, Miyo Kiyomizu, Mariko Teramoto, Yui Kitaoka & Hideo Honjo. (2007) Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells. Maturitas 56:2, pages 142-152.
Crossref
Crossref
J.F. Arnal, V. Douin-Echinard, L. Brouchet, F. Tremollières, H. Laurell, F. Lenfant, A.P. Gadeau, J.C. Guery & P. Gourdy. (2006) Understanding the oestrogen action in experimental and clinical atherosclerosis. Fundamental and Clinical Pharmacology 20:6, pages 539-548.
Crossref
Crossref
Jennifer Blake. (2006) Menopause: evidence-based practice. Best Practice & Research Clinical Obstetrics & Gynaecology 20:6, pages 799-839.
Crossref
Crossref
Ilana Löwy & Jean-Paul Gaudillière. (2006) Médicalisation de la ménopause, mouvements pour la santé des femmes et controverses sur les thérapies hormonales. Nouvelles Questions Féministes Vol. 25:2, pages 48-65.
Crossref
Crossref
Fränzel J.B. van Duijnhoven, Carla H. van Gils, Irene D. Bezemer, Petra H.M. Peeters, Yvonne T. van der Schouw & Diederick E. Grobbee. (2006) Use of hormones in the menopausal transition period in the Netherlands between 1993 and 1997. Maturitas 53:4, pages 462-475.
Crossref
Crossref
Revital Bruchim Bar Sade, Angela Chetrit, Arie Figer, Moshe Z. Papa, Dov Flex, Shulamit Rizel & Eitan Friedman. (2006) Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers. European Journal of Cancer 42:5, pages 650-655.
Crossref
Crossref
Frédérique Kuttenn, Jean-Claude Souberbielle, Catherine Cormier, Hélène Scherrer, Jacqueline Conard & Olga Melik-Pashayan. (2006) Exploration de la ménopause. Revue Francophone des Laboratoires 2006:379, pages 26-31.
Crossref
Crossref
Hyoung Moo Park. (2006) Climacteric Symptoms & Hormone Therapy. Journal of the Korean Medical Association 49:1, pages 11.
Crossref
Crossref
Claudia M. Greiser, Eberhard M. Greiser & Martina Dören. (2005) Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials. Human Reproduction Update 11:6, pages 561-573.
Crossref
Crossref
Angèle Gayet-Ageron, Nassira Amamra, Virginie Ringa, Valérie Tainturier, Claudine Berr, Françoise Clavel-Chapelon, Cécile Delcourt, Pierre D. Delmas, Pierre Ducimetière & Anne-Marie Schott. (2005) Estimated numbers of postmenopausal women treated by hormone therapy in France. Maturitas 52:3-4, pages 296-305.
Crossref
Crossref
T. Chevallier, J.-P. Daurès, M.-C. Micheletti*J.-Y. Reginster & J.-Y. Reginster. (2005) Méthodologie de l’enquête MISSION (Ménopause, rISque de cancer du SeIn, mOrbidité et prévaleNce). Journal de Gynécologie Obstétrique et Biologie de la Reproduction 34:7, pages 658-665.
Crossref
Crossref
Arvind Vashisht, Fred Wadsworth, Adam Carey, Beverley Carey & John Studd. (2005) Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime. BJOG: An International Journal of Obstetrics & Gynaecology 112:10, pages 1402-1406.
Crossref
Crossref
Maria Grazia Modena, Piero Sismondi, Alfred O. Mueck, Frédérique Kuttenn, Bruno de Lignières, Johan Verhaeghe, Jean Michel Foidart, Anne Caufriez & Andrea Riccardo Genazzani. (2005) New evidence regarding hormone replacement therapies is urgently required. Maturitas 52:1, pages 1-10.
Crossref
Crossref
Elizabeth A Krämer, Harald Seeger, Bernhard Krämer, Diethelm Wallwiener & Alfred O Mueck. (2005) The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells. Menopause 12:4, pages 468-474.
Crossref
Crossref
Carlo Campagnoli, Françoise Clavel-Chapelon, Rudolf Kaaks, Clementina Peris & Franco Berrino. (2005) Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 96:2, pages 95-108.
Crossref
Crossref
. 2005. Current Management of the Menopause. Current Management of the Menopause
i
xxv
.
John C. Stevenson. (2005) Justification for the use of HRT in the long-term prevention of osteoporosis. Maturitas 51:2, pages 113-126.
Crossref
Crossref
V. Beck, U. Rohr & A. Jungbauer. (2005) Phytoestrogens derived from red clover: An alternative to estrogen replacement therapy?. The Journal of Steroid Biochemistry and Molecular Biology 94:5, pages 499-518.
Crossref
Crossref
Andrea Micheli, Paola Muti, Giorgio Secreto, Vittorio Krogh, Elisabetta Meneghini, Elisabetta Venturelli, Sabina Sieri, Valeria Pala & Franco Berrino. (2004) Endogenous sex hormones and subsequent breast cancer in premenopausal women. International Journal of Cancer 112:2, pages 312-318.
Crossref
Crossref
Regine Sitruk-Ware & Genevieve Plu-Bureau. (2004) Exogenous progestagens and the human breast. Maturitas 49:1, pages 58-66.
Crossref
Crossref
Marco Gambacciani & Francesca Vacca. (2014) Estro-progestinici in menopausa: benefici e rischi. L'Endocrinologo 5:3-4, pages 104-110.
Crossref
Crossref
Edgar D Staren & Shuab Omer. (2004) Hormone replacement therapy in postmenopausal women. The American Journal of Surgery 188:2, pages 136-149.
Crossref
Crossref
Johannes Huber. (2004) Evidenzbasierte Entscheidungsgrundlagen für oder gegen eine postmenopausale Hormonbehandlung. Wiener Klinische Wochenschrift 116:14, pages 504-504.
Crossref
Crossref
René Druckmann. (2003) Progestins and their effects on the breast. Maturitas 46, pages 59-69.
Crossref
Crossref
John Studd. (2003) “Up to general practice to pick up the pieces”—what pieces?—a response to WHI and MWS. Maturitas 46:2, pages 95-96.
Crossref
Crossref